HSFs drive transcription of distinct genes and enhancers during oxidative stress and heat shock.
Samu V HimanenMikael C PuustinenAlejandro J Da SilvaAnniina VihervaaraLea SistonenPublished in: Nucleic acids research (2022)
Reprogramming of transcription is critical for the survival under cellular stress. Heat shock has provided an excellent model to investigate nascent transcription in stressed cells, but the molecular mechanisms orchestrating RNA synthesis during other types of stress are unknown. We utilized PRO-seq and ChIP-seq to study how Heat Shock Factors, HSF1 and HSF2, coordinate transcription at genes and enhancers upon oxidative stress and heat shock. We show that pause-release of RNA polymerase II (Pol II) is a universal mechanism regulating gene transcription in stressed cells, while enhancers are activated at the level of Pol II recruitment. Moreover, besides functioning as conventional promoter-binding transcription factors, HSF1 and HSF2 bind to stress-induced enhancers to trigger Pol II pause-release from poised gene promoters. Importantly, HSFs act at distinct genes and enhancers in a stress type-specific manner. HSF1 binds to many chaperone genes upon oxidative and heat stress but activates them only in heat-shocked cells. Under oxidative stress, HSF1 localizes to a unique set of promoters and enhancers to trans-activate oxidative stress-specific genes. Taken together, we show that HSFs function as multi-stress-responsive factors that activate distinct genes and enhancers when encountering changes in temperature and redox state.
Keyphrases
- heat shock
- heat stress
- genome wide
- oxidative stress
- genome wide identification
- transcription factor
- induced apoptosis
- stress induced
- dna methylation
- heat shock protein
- cell cycle arrest
- bioinformatics analysis
- genome wide analysis
- endoplasmic reticulum stress
- copy number
- dna damage
- single cell
- cell proliferation
- circulating tumor cells
- gene expression
- signaling pathway
- rna seq
- high throughput
- drug delivery
- cancer therapy
- cell death